We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop

By LabMedica International staff writers
Posted on 26 Jan 2023
Print article
Image: Researchers have measured thousands of molecules from a single drop of blood (Photo courtesy of Pexels)
Image: Researchers have measured thousands of molecules from a single drop of blood (Photo courtesy of Pexels)

“Multi-omics” technologies are capable of simultaneously analyzing various proteins, fats, by-products of metabolism and inflammatory markers. While finger-prick testing for diabetes measures a single type of molecule (glucose), multi-omics microsampling provides data regarding thousands of different molecules at once. Rather than focus on any single protein, metabolite or inflammatory marker, “omics” research adopts a broader, systems-biology approach by analyzing the entire spectrum of proteins (the proteome), fats (the lipidome) or the by-products of metabolism (the metabolome). Some recent advances have made this data analysis more robust and efficient, although the real-world usefulness of “multi-omics” research has been limited by various challenges, particularly the difficulties in sample collection. Several samples may be required to be taken within a short time span in order to measure a person’s response to a food or medication. Presently, sampling requires a person to travel to a clinic for an intravenous blood draw of 10 to 50 milliliters. Now, that could change after researchers have shown that they can measure thousands of molecules from a single drop of blood by using a new approach that combines a microsampling device with “multi-omics” technologies.

Researchers at Stanford Medicine (Stanford, CA, USA) set out to investigate whether it was possible to sharply reduce the volume of blood required for “multi-omics” analysis, but could still profile thousands of molecules. For their study, the researchers chose a microsampling device called Mitra, a portable finger-stick device that draws 10 microliters of blood into a gel matrix, and went on to test multiple extraction techniques for separating out the proteins, lipids and metabolites. In order to measure the inflammatory markers, the researchers used a second separate microsample. In a pilot study involving two test subjects, the researchers managed to measure the levels of 128 proteins, 1,461 metabolites and 776 lipids from each microsample. The team also monitored the samples for stability after storing them at various temperatures and found very few proteins to be unstable, irrespective of the temperature levels. They found that some lipids and metabolites broke down during storage at particular temperatures, although most of them remained stable.

A comparison of the “multi-omics” results obtained through microsampling with those from a traditional blood draw revealed similar results from the two collection types for most of the molecules. The researchers now became confident of the reliability of their multi-omic microsamples and went on to test the applications for the new technique. They analyzed data from 28 subjects for four hours after they had consumed a specific quantity of carbohydrates, fats, proteins and micronutrients from a meal replacement shake to monitor its molecular impact. The researchers found that people responded differently to the mixture. While people can have very different metabolic responses to the same food, standard blood tests are unable to provide sufficient data to understand why this is so.

The researchers eventually detected almost 50% of the compounds in the shake in the blood of the participants. After dividing the participants into two groups based on how quickly the molecules changed in their blood, the team found that one group responded more quickly to the shake than the other. Participants diagnosed with insulin resistance were more likely to come under the “fast responder” group. Some participants also exhibited an inflammatory reaction, with the molecules involved in their immune response peaking about 30 minutes after consumption of the shake. In a second experiment, the team sampled a researcher’s blood after every one to two hours while he was awake for a week. At the end of the week, the team had made 214,661 biochemical measurements, including levels of proteins, fats and hormones such as cortisol, which were compared with physiologic data obtained from wearable sensors.

The researchers observed that several molecules exhibited previously unidentified 24-hour rhythms (or certain molecules followed a daily, cyclic ebb and flow), while there were extensive variations in glucose and cortisol levels throughout the day, in contrast to their expectations. The researchers now plan to expand the pilot studies and offer multi-omic microsampling to a broader patient group. The researchers believe that in the future, healthy people could perform multi-omic microsampling at home every month, every week, or once a day to obtain a sense of their personal molecular fingerprint. Any subtle changes in this fingerprint could indicate the onset of a disease much before standard lab tests picked up any abnormality.

“The most exciting thing about microsampling is the ability to collect denser time points and more comprehensive data,” said Ryan Kellogg, PhD, post-doctoral researcher in genetics and one of four co-lead authors on the paper. “With traditional venipuncture, your doctor gets a sample every six months, or maybe even every few years. There’s a lot of biology happening between those samples.”

“Several ongoing projects are evaluating if this method can be used for early disease detection,” said Stanford postdoctoral scholar Xiaotao Shen, PhD, who was in charge of data analysis for the project. “Through longitudinal monitoring, we’re very hopeful this can be used for diagnosis.”

Related Links:
Stanford Medicine 

Gold Supplier
Auto Urinary Sediment Analyzer
EH-2030
New
Automated Electrolyte Analyzer
InSight
New
Gold Supplier
Cerebral Spinal Fluid Control
Multichem CSF
New
Mycoplasma Pneumoniae Assay
SeroMP

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more

Pathology

view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.